ARTICLE | Clinical News
Fluenz regulatory update
October 25, 2010 7:00 AM UTC
CHMP issued a positive opinion recommending approval of an MAA from AstraZeneca's MedImmune subsidiary for Fluenz intranasal live attenuated influenza vaccine (LAIV) from to prevent seasonal influenza...